Encompass Health Corp (EHC) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Encompass Health Corporation is the nation's largest owner and operator of inpatient rehabilitation hospitals (IRFs), operating 170 facilities across 39 states and Puerto Rico. The company operates as a single reportable segment focused on inpatient rehabilitation services, with significant concentrations in Florida and Texas.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Net Operating Revenues | $1,477.5M | $1,351.0M | $4,390.6M | $3,968.2M |
| Net Income (Total) | $174.6M | $147.1M | $556.0M | $432.4M |
| Net Income Attributable to EHC | $126.5M | $108.2M | $420.1M | $334.8M |
| Diluted EPS (EHC) | $1.24 | $1.06 | $4.11 | $3.28 |
| Adjusted EBITDA | $300.1M | $269.3M | $932.3M | $814.1M |
| Operating Cash Flow (9M) | $829.6M | $724.0M | - | - |
| Total Debt (Long-term + Current) | $2,432.9M | $2,497.8M | - | - |
| Cash & Equivalents | $48.7M | $85.4M | - | - |
Note: Total Debt excludes finance lease obligations of $300.8M. Cash excludes $45.0M in restricted cash.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 9.4% in Q3 and 10.6% YTD compared to 2024, driven by volume growth (5.0% discharge increase in Q3) and favorable pricing (3.3% increase in net patient revenue per discharge).
- Profitability: Net income attributable to Encompass Health rose 16.9% in Q3 and 25.5% YTD. Operating margins improved as total operating expenses decreased as a percentage of revenue (83.5% in Q3 2025 vs. 84.5% in Q3 2024).
- Debt Management: In September 2025, the company redeemed the remaining $100 million of its 5.75% Senior Notes due 2025 at maturity. Total debt decreased slightly due to this redemption and principal payments.
- Capital Allocation: The company repurchased $81.7 million of common stock YTD 2025 (vs. $23.6M in 2024) and increased the quarterly dividend to $0.19 per share.
- Expansion: The company opened four new hospitals and added 140 beds to existing facilities in 2025, contributing to volume growth.
Guidance, Outlook, and Risks
- Outlook: Management remains optimistic regarding long-term demand due to aging demographics. The company expects Medicare reimbursement rates to increase by approximately 2.9% effective October 1, 2025, under the new 2026 Final IRF Rule.
- Tax Impact: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 is expected to generate approximately $50 million in cash tax savings for 2025 through bonus depreciation and R&D expensing provisions.
- Capital Expenditures: The company expects to spend $785 million to $820 million on capital expenditures in 2025, with approximately $424 million in projects currently under construction.
- Key Risks:
- Regulatory & Reimbursement: Continued uncertainty regarding Medicare regulations, specifically the Review Choice Demonstration (RCD) in Alabama, where claim validation rates have fluctuated, potentially impacting collectability.
- Staffing: Ongoing challenges in recruiting and retaining nurses and therapists, though contract labor usage has decreased.
- Legal: Exposure to False Claims Act (qui tam) lawsuits and regulatory audits common in the healthcare industry.
Investor Verification Checklist
- Medicare RCD Impact: Verify the financial impact of the Review Choice Demonstration in Alabama, specifically the validation rates for the fourth cycle and potential recoupments.
- Debt Maturity Profile: Confirm the absence of significant debt maturities until 2028 and the status of the revolving credit facility ($873M available).
- Noncontrolling Interests: Review the increasing portion of net income attributable to noncontrolling interests (up 23.7% in Q3), reflecting profitability in joint venture hospitals.
- Capital Expenditure Execution: Monitor the $507M spent YTD against the $785M-$820M full-year budget and the timeline for new hospital openings.
- Tax Provision Realization: Track the realization of the estimated $50M cash tax savings from the OBBBA in the final quarter of 2025.